Melanoma therapeutics: a literature review

Pavan Kumar Dhanyamraju1, Trupti N Patel2

  • 1Department of Pediatrics and Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.

Insights

This review covers new melanoma treatments, including targeted therapies and immunotherapies. It highlights challenges like treatment resistance and future research directions for this skin cancer.

Area of Science:

  • Oncology
  • Dermatology
  • Cancer Biology

Background:

  • Melanoma, a severe skin cancer, is challenging to treat due to complex signaling pathways and late-stage diagnosis.
  • Current treatments like chemotherapy and immunotherapy face limitations due to developing treatment resistance.
  • Advances in genetic profiling have identified new molecular targets for melanoma therapy.

Purpose of the Study:

  • To provide a comprehensive overview of recently approved and emerging melanoma therapies.
  • To examine novel therapeutic strategies and their potential impact on melanoma treatment.
  • To discuss future directions and research opportunities in melanoma therapeutics.

Main Methods:

  • Literature review of recently approved and investigational melanoma therapies.
  • Analysis of molecular factors and signaling pathways involved in melanoma pathogenesis.
  • Synthesis of current treatment approaches and their efficacy.

Main Results:

  • Several new therapies, including targeted agents and immunotherapies, have been approved for melanoma treatment.
  • Emerging therapies show promise in overcoming treatment resistance and improving patient outcomes.
  • Understanding melanoma's molecular landscape is crucial for developing effective treatments.

Conclusions:

  • Recent therapeutic advancements offer new hope for melanoma patients, particularly those with advanced disease.
  • Continued research into novel molecular targets and combination therapies is essential.
  • Personalized medicine approaches based on genetic profiling will likely shape future melanoma treatment strategies.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K